Last reviewed · How we verify
pentoxyphilline
At a glance
| Generic name | pentoxyphilline |
|---|---|
| Sponsor | French National Agency for Research on AIDS and Viral Hepatitis |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- NCT02458079 (NA)
- Efficacy and Safety of the Association With Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C (Phase 3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- pentoxyphilline CI brief — competitive landscape report
- pentoxyphilline updates RSS · CI watch RSS
- French National Agency for Research on AIDS and Viral Hepatitis portfolio CI